---
title: "Bristol-Myers Squibb (BMY) Gets a Hold from Wells Fargo"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292483611.md"
description: "Wells Fargo analyst Mohit Bansal maintained a Hold rating on Bristol-Myers Squibb (BMY) with a $60 price target. This follows similar Hold ratings from RBC Capital and contrasts with a Buy rating from Bank of America Securities. Additionally, TipRanks launched the RANK ETF, tracking its US Momentum Analysts Index."
datetime: "2026-07-13T10:55:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292483611.md)
  - [en](https://longbridge.com/en/news/292483611.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292483611.md)
generator: "portal-rs"
---

# Bristol-Myers Squibb (BMY) Gets a Hold from Wells Fargo

In a report released today, Mohit Bansal from Wells Fargo maintained a Hold rating on Bristol-Myers Squibb, with a price target of $60.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

Bansal covers the Healthcare sector, focusing on stocks such as Merck & Company, Gilead Sciences, and Vertex Pharmaceuticals. According to TipRanks, Bansal has an average return of 11.1% and a 59.49% success rate on recommended stocks. 

In addition to Wells Fargo, Bristol-Myers Squibb also received a Hold from RBC Capital’s Trung Huynh in a report issued on July 10. However, on the same day, Bank of America Securities reiterated a Buy rating on Bristol-Myers Squibb (NYSE: BMY).

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [RY.US](https://longbridge.com/en/quote/RY.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [17,077 Shares in Bristol Myers Squibb Company $BMY Purchased by Avaii Wealth Management LLC](https://longbridge.com/en/news/296315075.md)
- [Patrick Mauro Investment Advisor INC. Acquires New Position in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/296468745.md)
- [North Dakota State Investment Board Boosts Holdings in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/296020226.md)
- [LaSalle St. Investment Advisors LLC Takes $1.12 Million Position in Bristol Myers Squibb Company $BMY](https://longbridge.com/en/news/296603017.md)
- [Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene](https://longbridge.com/en/news/296131073.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**